Novavax
NVAX
#5397
Rank
C$2.15 B
Marketcap
C$13.08
Share price
-2.47%
Change (1 day)
47.19%
Change (1 year)

Novavax (NVAX) - Total debt

Total debt on the balance sheet as of March 2026 : C$0.41 Billion

According to Novavax's latest financial reports the company's total debt is C$0.41 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Novavax - Total debt on balance sheet (from 1999 to 2026)

Total debt by year

Year Total debt Change
2025-12-31C$0.34 B3.05%
2024-12-31C$0.33 B8.82%
2023-12-31C$0.30 B-59.27%
2022-12-31C$0.74 B28.94%
2021-12-31C$0.57 B-3.04%
2020-12-31C$0.59 B41.94%
2019-12-31C$0.42 B-3.31%
2018-12-31C$0.43 B8.83%
2017-12-31C$0.39 B-6.02%
2016-12-31C$0.42 B77483.14%
2015-12-31C$0.54 M-52.69%
2014-12-31C$1.15 M-42.16%
2013-12-31C$2 M67.1%
2012-12-31C$1.19 M268.12%
2011-12-31C$0.32 M-18.59%
2010-12-31C$0.39 M-21.81%
2009-12-31C$0.51 M-98.16%
2008-12-31C$27.85 M22.73%
2007-12-31C$22.69 M-15.94%
2006-12-31C$26.99 M-24.04%
2005-12-31C$35.54 M-20.37%
2004-12-31C$44.63 M-18.39%
2003-12-31C$54.69 M-16.36%
2002-12-31C$65.39 M19.55%
2001-12-31C$54.7 M82.55%
2000-12-31C$29.96 M20675.29%
1999-12-31C$0.14 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novartis
NVS
C$66.36 B 15,828.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$89.99 B 21,499.14%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$47.89 B 11,395.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$35.63 B 8,453.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
C$1.46 B 251.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C$2.69 M-99.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$64.63 M-84.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
C$2.11 M-99.49%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
C$1.15 B 177.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.93 B 124.74%๐Ÿ‡บ๐Ÿ‡ธ USA